208 related articles for article (PubMed ID: 24040340)
1. C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines.
Holliday MW; Cox SB; Kang MH; Maurer BJ
PLoS One; 2013; 8(9):e74768. PubMed ID: 24040340
[TBL] [Abstract][Full Text] [Related]
2. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.
Wang H; Maurer BJ; Liu YY; Wang E; Allegood JC; Kelly S; Symolon H; Liu Y; Merrill AH; Gouazé-Andersson V; Yu JY; Giuliano AE; Cabot MC
Mol Cancer Ther; 2008 Sep; 7(9):2967-76. PubMed ID: 18790777
[TBL] [Abstract][Full Text] [Related]
3. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.
Casasampere M; Ordóñez YF; Casas J; Fabrias G
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):264-275. PubMed ID: 27894925
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells.
Ridgway ND; Merriam DL
Biochim Biophys Acta; 1995 Apr; 1256(1):57-70. PubMed ID: 7742357
[TBL] [Abstract][Full Text] [Related]
5. Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.
Apraiz A; Idkowiak-Baldys J; Nieto-Rementería N; Boyano MD; Hannun YA; Asumendi A
Biochem Cell Biol; 2012 Apr; 90(2):209-23. PubMed ID: 22428532
[TBL] [Abstract][Full Text] [Related]
6. Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy.
Gagliostro V; Casas J; Caretti A; Abad JL; Tagliavacca L; Ghidoni R; Fabrias G; Signorelli P
Int J Biochem Cell Biol; 2012 Dec; 44(12):2135-43. PubMed ID: 22960157
[TBL] [Abstract][Full Text] [Related]
7. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells.
Kraveka JM; Li L; Szulc ZM; Bielawski J; Ogretmen B; Hannun YA; Obeid LM; Bielawska A
J Biol Chem; 2007 Jun; 282(23):16718-28. PubMed ID: 17283068
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of ceramide molecular species by high performance liquid chromatography.
Yano M; Kishida E; Muneyuki Y; Masuzawa Y
J Lipid Res; 1998 Oct; 39(10):2091-8. PubMed ID: 9788256
[TBL] [Abstract][Full Text] [Related]
9. Effects of sphingoid bases on the sphingolipidome in early keratinocyte differentiation.
Sigruener A; Tarabin V; Paragh G; Liebisch G; Koehler T; Farwick M; Schmitz G
Exp Dermatol; 2013 Oct; 22(10):677-9. PubMed ID: 24079743
[TBL] [Abstract][Full Text] [Related]
10. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells.
Signorelli P; Munoz-Olaya JM; Gagliostro V; Casas J; Ghidoni R; Fabriàs G
Cancer Lett; 2009 Sep; 282(2):238-43. PubMed ID: 19394759
[TBL] [Abstract][Full Text] [Related]
11. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
12. Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cells.
Mao Z; Sun W; Xu R; Novgorodov S; Szulc ZM; Bielawski J; Obeid LM; Mao C
J Biol Chem; 2010 Sep; 285(38):29078-90. PubMed ID: 20628055
[TBL] [Abstract][Full Text] [Related]
13. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
[TBL] [Abstract][Full Text] [Related]
14. The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.
Muñoz-Guardiola P; Casas J; Megías-Roda E; Solé S; Perez-Montoyo H; Yeste-Velasco M; Erazo T; Diéguez-Martínez N; Espinosa-Gil S; Muñoz-Pinedo C; Yoldi G; Abad JL; Segura MF; Moran T; Romeo M; Bosch-Barrera J; Oaknin A; Alfón J; Domènech C; Fabriàs G; Velasco G; Lizcano JM
Autophagy; 2021 Jun; 17(6):1349-1366. PubMed ID: 32397857
[TBL] [Abstract][Full Text] [Related]
15. Dihydroceramide Desaturase Functions as an Inducer and Rectifier of Apoptosis: Effect of Retinol Derivatives, Antioxidants and Phenolic Compounds.
Alsanafi M; Brown RDR; Oh J; Adams DR; Torta F; Pyne NJ; Pyne S
Cell Biochem Biophys; 2021 Sep; 79(3):461-475. PubMed ID: 33991313
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in study of dihydroceramide].
Li FF; Zhang D; Bao XQ; Sun H
Yao Xue Xue Bao; 2016 Sep; 51(9):1388-93. PubMed ID: 29924512
[TBL] [Abstract][Full Text] [Related]
19. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide.
Michel C; van Echten-Deckert G; Rother J; Sandhoff K; Wang E; Merrill AH
J Biol Chem; 1997 Sep; 272(36):22432-7. PubMed ID: 9312549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
